Related Experiment Video
Updated: Aug 12, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
[Epileptic patient compliance with prescribed medical treatment]
Ivo Lusić1, Marina Titlić, Davor Eterović
1Odjel za neurologiju, Klinicka bolnica Split, Split, Hrvatska. ivo.lusic@st.tel.hr
Abstract:
Medically treated patients' non-compliance with the prescribed scheme is an exceptionally important issue, faced relatively often in medical treatment of epilepsy.
Objective, Patients And Methods:
Different demographic and clinical data, collected upon questionnaire completion from 146 patients suffering from epilepsy, were sorted out and integrated in the present research analyses with the objective to determine the possible correlation of collected data and compliance level recorded in the observed patients.
Results And Discussion:
Generally, the subjects took pretty the prescribed therapy regularly: in 62% of subjects the compliance level was recorded as good, in 23% as satisfactory, and in the remaining 15% as unsatisfactory. The following factors were identified as possible predictors of the less precise adherence to the prescribed therapeutic regimen (p<0.01): regular consumption of alcohol, medical treatment of 6 or more years, and three or more daily drug doses. The correlation between the greater number of prescribed anti-epileptic medicines and lower compliance level (p=0.05) was also assessed. The study revealed a tendency towards lower compliance level in patients aged below 30. Surprisingly, the same tendency was observed in the subjects with more thoroughly controlled epileptic condition. In spite of different experiments aimed to improve the regularity in taking the prescribed therapy, the issue of non-compliance still poses a considerable obstacle to the more successful treatment of epileptic patients.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Drug Therapy
Antianxiety Medications

